Danielle Duffy Selected Research

Danielle Duffy Research Topics

Disease

14	Myocardial Infarction 05/2024 - 11/2014
7	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 11/2014
5	Atherosclerotic Plaque (Atheroma) 01/2023 - 07/2005
4	Atherosclerosis 01/2022 - 01/2006
4	Coronary Disease (Coronary Heart Disease) 11/2017 - 01/2006
3	Stroke (Strokes) 04/2024 - 11/2014
3	Dyslipidemias (Dyslipidemia) 05/2015 - 07/2005
2	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 01/2021
2	Acute Coronary Syndrome 01/2022 - 11/2016
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2016 - 09/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2009 - 01/2006
2	Insulin Resistance 02/2007 - 01/2006
2	Inflammation (Inflammations) 02/2007 - 01/2006
1	Hypersensitivity (Allergy) 04/2024
1	Thrombosis (Thrombus) 03/2024
1	Rupture 01/2022
1	Peripheral Arterial Disease 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Homozygous Familial Hypercholesterolemia 08/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2015
1	Unilateral Breast Neoplasms 05/2015
1	Stomach Ulcer (Gastric Ulcer) 11/2014
1	Transient Ischemic Attack 11/2014
1	Prostatic Neoplasms (Prostate Cancer) 09/2014
1	Back Pain (Backache) 09/2014
1	Bradycardia 09/2014
1	Disease Progression 09/2014
1	Hypercholesterolemia 03/2014
1	ST Elevation Myocardial Infarction 04/2012
1	Non-ST Elevated Myocardial Infarction 04/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2007
1	Weight Loss (Weight Reduction) 02/2007
1	Obesity 02/2007
1	Abdominal Obesity 02/2007

Drug/Important Bio-Agent (IBA)

13	CSL112IBA 05/2024 - 01/2019
13	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2024 - 07/2005
11	CholesterolIBA 04/2024 - 07/2009
6	LipidsIBA 01/2022 - 05/2015
5	human APOA1 proteinIBA 05/2024 - 01/2019
4	HDL LipoproteinsIBA 04/2024 - 07/2005
4	HDL CholesterolIBA 01/2021 - 01/2006
4	oxidized low density lipoproteinIBA 06/2016 - 01/2006
3	Lipoproteins (Lipoprotein)IBA 09/2014 - 01/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2017 - 11/2016
2	BMS201038IBA 08/2015 - 03/2014
2	Triglycerides (Triacylglycerol)IBA 01/2009 - 01/2006
2	PPAR alphaIBA 01/2009 - 07/2005
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	CER-001IBA 01/2022
1	MDCO-216IBA 01/2022
1	ApoproteinsIBA 01/2022
1	CreatinineIBA 01/2019
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2019
1	Sucrose (Saccharose)IBA 01/2019
1	mipomersenIBA 08/2015
1	Lipoprotein(a)IBA 05/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2014
1	Digoxin (Digitek)FDA LinkGeneric 09/2014
1	microsomal triglyceride transfer proteinIBA 03/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2009
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 01/2009
1	Apolipoprotein B-100 (Apo B 100)IBA 01/2009
1	LY 518674IBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 03/2007
1	RimonabantIBA 02/2007
1	EndocannabinoidsIBA 02/2007
1	AdiponectinIBA 01/2006
1	Pioglitazone (Actos)FDA Link 01/2006
1	AdipokinesIBA 01/2006
1	PPAR-gamma AgonistsIBA 07/2005
1	Fibric Acids (Fibrates)IBA 07/2005
1	Phospholipids (Phosphatides)FDA LinkGeneric 07/2005

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2006
1	Stents 03/2024
1	Drug Therapy (Chemotherapy) 01/2021
1	Radiotherapy 05/2015
1	Secondary Prevention 11/2014